Gwrthrychau elusennol
3. THE CHARITABLE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE THE PRESERVATION, PROMOTION AND ADVANCEMENT OF HUMAN HEALTH AND WELFARE AND THE ADVANCEMENT AND PROMOTION OF KNOWLEDGE AND EDUCATION FOR THE BENEFIT OF THE PUBLIC BY: 3.1 ENHANCING AND PROMOTING KNOWLEDGE OF AND ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO THE MECHANISMS OF CELL DEGENERATION, REGENERATION AND MALFUNCTION AND THEIR LINKS TO DEGENERATIVE AND OTHER DISEASES, DISABILITIES, DISORDERS AND CONDITIONS IN RESPECT OF WHICH STEM CELL RELATED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS OR TECHNOLOGIES MIGHT BE BENEFIT; 3.2 ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO STEM CELL AND STEM CELL-BASED OR DERIVED METHODS AND TECHNOLOGIES, WITH A VIEW TO DISCOVERING, INVENTING, IMPROVING, DEVELOPING, PRODUCING AND APPLYING MEDICINE, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES, INCLUDING THE TRANSLATION OF PURE RESEARCH INTO OUTPUTS TO A STANDARD SUSCEPTIBLE OF CLINICAL TRIALS WITH A VIEW TO ESTABLISHING THE EFFICACY AND SUPPORTING THE CLINICAL DEVELOPMENT OF MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES CAPABLE OF APPLICATION; 3.3 EDUCATING AND INFORMING THE PUBLIC IN RELATION TO STEM CELLS AND THE EFFICACY OF STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES; AND 3.4 PROMOTING THE ETHICAL USE OF STEM CELLS WHETHER IN RESEARCH, DEVELOPMENT OR OTHERWISE AND THE ETHICAL USE AND PRODUCTION OF STEM CELLS AND STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES AND THE APPROPRIATE REGULATION AND MANAGEMENT THEREOF AND EDUCATING AND INFORMING THE PUBLIC IN RELATION TO SUCH MATTERS.
